Well be looking at a few things as we head into 2026 here: Will the rise in warning letters continue, or was FY 2025 an outlier reflecting catch-up activity
Regulatory approval follows rigorous trials, and some GLP-1 drugs are approved for obesity management, others for type 2 diabetes
Consistency is critical
When the bodys antioxidant defenses, such as Glutathione, are depleted, oxidative damage can increase, and cells can become less responsive to insulin
Profiles Drug Subst Excip Relat Method
In the GLP-1 RA vs SGLT-2 inhibitor cohort, there was no difference in the adjusted HR of suicide or suicide attempts between patients treated with GLP-1 RAs compared with patients treated with SGLT-2 inhibitors after 1 year of follow-up (HR 365 0.93 [0.57;1.52]), see Table 2